Two simple and rapid titrimetric methods are described for the determination of bupropion hydrochloride (BUPH) in pharmaceuticals. The proposed methods are based on the solvent extraction-titration of BUPH with two ion-association reagents, i.e., sodium lauryl sulphate (SLS) and tetraphenylborate (TPB). In method A, SLS was used as titrant and the titration was carried out in the presence of dilute sulphuric acid and chloroform using dimethyl yellow as indicator whereas in method B, the titrant was TPB and the titration was done in borate-phosphate buffer of pH 6.0 and 1,2-dichloroethane with tetrabromophenolphthalein ethyl ester (TBPE) as indicator. In the two-phase titrations, the proposed procedures give sharp end points as the color of the organic phase changes from yellow to pink in method A and from red-violet to yellow in method B. The methods are applicable over the ranges of 1.0-20.0 and 3.0-10.0 mg of BUPH for methods A and B, respectively. The accuracy and precision of the methods are good. The methods were applied successfully to the determination of BUPH in tablets and the results were in agreement with the label claim and those of the comparison method. Key words: bupropion hydrochloride; ion-association titration; dimethyl yellow; tetrabromophenolphthalein ethyl ester; pharmaceuticals.
graphy (LC) [13] [14] [15] , liquid chromatography mass spectrometry (LC-MS) [16] , liquid chromatography--tandem mass spectrometry (LC-MS/MS) [17] [18] [19] , liquid chromatography electrospray ionization-tandem mass spectrometry (LC/ESI/MS/MS) [20] , capillary electrophoresis [21] and radioimmunoassay [22] . Several methods have been reported for the determination of BUPH in pharmaceuticals such as non--aqueous titration [23] , HPLC [23] [24] [25] [26] , gas liquid chromatography (GLC) [27] , LC [28] , thin-layer chromatography (TLC) [29] , capillary electrophoresis [21] , polarography [30] , potentiometry [31] , conductometry [31] , UV-spectrophotometry [31, 32] and visible spectrophotometry [33, 34] . The reported methods are applicable only over the microgram level and the assay procedure for the determination of BUPH in the milligram level is of paramount importance in large-scale analysis. Therefore, highly precise stoichiometric reaction with a reagent possessing antagonistic properties for the assay of pharmaceuticals using titrimetric procedure is still the choice of many pharmacopoeias [35, 36] . Titrimetry may serve as a useful alternative to many of the aforesaid sophisticated techniques because of its cost-effectiveness, ease of operation, remarkable accuracy and precision and wide applicability. To the best of our knowledge, there are only two reports dealing with titrimetric procedures for the determination of BUPH in pharmaceuticals [23, 31] . The reported chromatographic techniques, although sensitive, require expensive instrumental-set up, large quantities of organic solvents, which are expensive. In addition, many chromatographic methods need a suitable compound as internal standard, which make the analytical procedure more complex.
Two-phase titrations (ion-pair extraction titrations or ion-association titrations) employing indicators for visual end-point detection are already well established for the determination of surfactants [37] [38] [39] [40] [41] , amines [42] [43] [44] , ammonium compounds [42] [43] [44] [45] and pharmaceutical substances [42, 43, [46] [47] [48] [49] [50] [51] . The characteristic of the ion-association titration methods consist in the use of a two-phase (water-organic solvent) system. The end point detection is based on the different stabilities of the ion-associations formed between the determined substance with the titrant and with the indicator [46] . This paper presents two ion-association titration methods for the determination of BUPH in pharmaceuticals. The methods employ sodium lauryl sulphate or sodium tetraphenylborate as the titrant with the determinations carried out in the presence of sulphuric acid-chloroform or borate-phosphate buffer (pH 6) and 1,2-dichloroethane with dimethyl yellow or tetrabromophenolphthalein ethyl ester (TBPE) as the indicator. The methods allow a quick determination of BUPH in bulk drug and in tablets without requiring pre-treatment of the samples, with high accuracy and precision, and without interference from excipients.
EXPERIMENTAL Apparatus
An Elico LI 610 digital pH meter provided with a combined glass-SCE electrode system (Elico Ltd., Hyderabad, India) was used to record the pH and an Equip-Tronics magnetic stirrer model EQ-770 was used to carry out the titration successfully.
Materials and reagents
All chemicals and reagents used were of analytical reagent grade and distilled water was used throughout. The solvents used were of HPLC grade.
Pharmaceutical grade BUPH was received from GlaxoSmithKline Pharmaceuticals, Mumbai, India, and certified to be 99.78% pure. The following pharmaceutical preparations were purchased from commercial sources in the local market and subjected to analysis: Bupron-SR-150 from Sun Pharmaceutical Industries, Jammu, India, and Ession-ER-150 from Psycoremedies, Ludhiana, Punjab, India.
A stock standard solution containing 2.0 mg mL -1 BUPH solution was prepared in water. A 0.008 M sodium lauryl sulfate (99.0%, LOBA Chemie PVT. Ltd., Mumbai, India) was prepared in water and standardized using benzethonium chloride [52] , 0.01% (w/v) dimethyl yellow (DMY) (Rolex Laboratory Reagent, Mumbai, India) was prepared in absolute ethanol and 2 M sulphuric acid was prepared by appropriately diluting concentrated sulfuric acid (Merck, Mumbai, India, Sp. gr. 1.84) with water.
A 0.004 M solution of tetraphenylborate was prepared by dissolving the required amount of sodium tetraphenylboron (99.5%, S.D. Fine Chem., Mumbai, India) in water then diluted to 250 mL with 0.001 M sodium hydroxide solution and standardized following the recommended procedure in Japanese Pharmacopoeia [53] , 0.2% (w/v) TBPE (Sigma-Aldrich, Inc., USA) solution was prepared in absolute ethanol and the borate-phosphate buffer solution of pH 6 was prepared by mixing 0.3 M sodium dihydrogenphosphate (S. D. fine Chem Ltd., Mumbai, India) and 0.1 M sodium tetraborate (S. D. fine Chem Ltd., Mumbai, India) and the pH adjusted with 2 M sulphuric acid.
Chloroform and 1,2-dichloroethane (DCE) (Merck, Mumbai, India) and absolute ethanol were used without any purification.
Procedures
Method A. Different aliquots (0.5-10 mL) of standard BUPH (2.0 mg mL -1 ) solution were transferred into a 50 mL beaker and the volume was adjusted to 13 mL with water. Two mililiters of 2 M H 2 SO 4 , 0.5 mL of 0.01% DMY and 10 mL of chloroform were added and the mixture was stirred on a magnetic stirrer for 1 min. The mixture was then titrated with 0.008 M SLS with vigorous stirring until a color change from yellow to pink takes place in the organic phase at the endpoint. A reagent blank prepared in the same way was titrated and the necessary corrections were applied to the sample titer volume. Each mL of 0.008 M SLS is equivalent to 2.2096 mg of BUPH.
Method B. Different aliquots of the standard solution (1.5-5.0 mL, 2.0 mg mL -1 ) of pure BUPH were accurately transferred into a 50 mL beaker and the volume was adjusted to 5 mL with water. Five milliliters of the borate-phosphate buffer (pH 6.0), 2 drops of TBPE indicator solution and 10 mL of DCE were added and mixed well by magnetic stirring. The mixture was titrated against 0.004 M TPB solution with vigorous stirring until the color of the organic phase changes from red-violet to yellow at the end point. It is not necessary to make a blank titration because the color of the organic phase is yellow in the absence of the drug. Each mL of 0.004 M TPB is equivalent to 1.1048 mg of BUPH.
Procedures for tablets
Ten tablets (Bupron SR 150 or Ession ER 150) containing BUPH were weighed accurately and ground into a fine powder. An amount of powder equivalent to 200 mg of BUPH was weighed into a 100 mL calibrated flask containing about 60 mL of water. The extraction was done by shaking thoroughly for about 20 min; then the volume was made up to the mark with water, mixed well and filtered using a Whatman No. 42 filter paper. The first 10 mL of the filtrate were discarded in order to avoid small dilution in the concentration of BUPH because of the wet filter paper. Different volumes of the resulting solution (2.0 mg mL -1 BUPH, the nominal concentration) were used in the analysis. (4.0 mL for Bupron SR 150) and (3.0 mL for Ession ER 150) were subjected to titration by applying the procedure described in method A. Also, (1.5 mL for Bupron SR 150) and (2.0 mL for Ession ER 150) were subjected to titration following the procedure of method B.
RESULTS AND DISCUSSION
The two-phase ion-association titration was applied to the determination of some basic pharmaceutical compounds using indicators for visible end-point detection. Earlier, the end-point detection in this type of titrations was based on the movement of the indicator from one phase to other and it was difficult to detect the end point because the color of the indicator in the aqueous phase or organic phase will be reflected in the other phase [51] . An alternative approach is to use hydrophobic indicators, which remain in the organic phase throughout the titration and give a very sharp color change [54] . Eppert and Liebscher [55] used dimethyl yellow (cationic) indicator in their titration whereas Tsubouchi et al. [56] used the potassium salt of the ethyl ester of tetrabromophenolphthalein (anionic) indicator for the two-phase titration. The above indicators are useful in the detection of the end point as the color change depends on the pH (Figure 2 ).
Method development
Development of method A. This is based on the formation of an ion-association complex between the BUPH and the titrant, i.e., SLS, in acid medium using DMY as indicator and chloroform as extracting solvent. The effect of the acid and the extracting solvent were optimized and it was found that 2 mL of 2 M sulphuric acid in a total volume of 15 mL of aqueous phase, and chloroform as solvent (10 mL) gave reproducible and stoichiometric results in the range investigated. When DMY indicator was added to BUPH solution in the presence of 2 M H 2 SO 4 and chloroform, and stirring the contents by a magnetic stirrer, the aqueous phase became colorless and a yellow color resulted in the chloroform layer due to non solubility of the DMY in water. A yellow color was developed in the chloroform phase, because of the presence of the indicator in a molecular form. When the drug sample was titrated with SLS solution, the protonated drug (R 2 NH 2 + ) formed a colorless ion-association complex (R 2 NH 2 + ·Titrant ‫ــ‬ ), which would be extracted into the organic phase. When the equivalence point was reached and one drop excess of the titrant was added, the color of organic phase changed from yellow to pink due to the formation of cationic form of DMY indicator, i.e., DMYH + (Figure 2) , which is stabilized by the formation of stable ion-pair complex (DMYH + ·SLS ‫ــ‬ ) with the titrant in the organic phase. Three water-immiscible solvents such as chloroform, dichloromethane and 1,2-dichloroethane were tested as an extracting solvent. When dichloromethane was used, a pink color starts to appear in the aqueous phase before adding the titrant. The colorless aqueous layer was observed in case of both chloroform and 1,2-dichloroethane but the former was preferred as a sharp color change at the end point was observed.
The chemical reactions which form the basis for this method can be formulated as follow.
Before the addition of titrant: Development of method B. This is based on the formation of an ion-pair complex between the BUPH and TPB as titrant in a solution buffered at pH 6 using TBPE as indicator and 1,2-dichloroethane as extracting solvent. The complex formed in this method is highly pH dependent, so the effect of pH was studied carefully and it was found that 5 mL of borate-phosphate buffer (pH 6.0) in a total volume of 10 mL of aqueous phase and 10 mL of DCE solvent gave the best end-points and most consistent titers. When BUPH solution, buffer solution, DCE and TBPE indicator solution were mixed well, the aqueous phase became colorless, and a red-violet color developed in the DCE phase, because the indicator forms an organophilic ion-pair complex with the drug. When the drug sample was titrated with TPB solution, the protonated drug (R 2 NH 2 + ) formed colorless ion-association (R 2 NH 2 + · ·Titrant ‫ـــ‬ ) which will be extracted into the organic phase. Near the equivalence point of the titration, the organic phase began to turn green. When one drop excess of the titrant was added, the color of the organic phase changed from red-violet to yellow due to the formation of molecular form of the indicator, i.e., TBPEH (Figure 2) .
The effect of the same organic solvents studied in method A was tested in method B. The results showed that when chloroform was used, the red-violet color of drug-indicator complex could not be obtained before any addition of the titrant. This red-violet color was obtained with both other solvents i.e. dichloromethane and 1,2-dichloroethane, but the latter was the best to determine the end point exactly and easily.
The chemical reactions for this titration can be explained as follows.
Before addition the titrant: 
The validation of the methods was done according to the present ICH guidelines [57] .
Range and stoichiometry
The proposed procedures are applicable over the ranges of 1.0-20 and 3.0-10 mg of BUPH for methods A and B, respectively. The reaction stoichiometry was calculated to be 1:1 for both methods (BUPH: SLS) in method A and (BUPH:TPB) in method B, owing to the presence of one nitrogen atom in the BUPH.
Accuracy and precision
The accuracy of an analytical method expresses the closeness between the reference value and the found value [57] . Accuracy was evaluated as percentage relative error (%RE) between the measured and taken amounts of BUPH. The results, compiled in Table 1 , show that the accuracy of both methods is satisfactory (RE ≤ 2.16%). The precision of the methods was calculated in terms of intermediate precision (intra-day and inter-day) [58] . Three different concentration of BUPH (within the working limits) were analyzed in seven replicates during the same day (intra-day precision) and five consecutive days (inter-day precision). The percentage relative standard deviation (%RSD) values were ≤1.98 (intra-day) and ≤2.13 (inter-day) indicating that the precision was high for both methods (Table 1) .
Selectivity
In order to evaluate the selectivity of the proposed methods, the effect of the presence of common excipients present in the formulations was tested for possible interference in the assay by placebo and synthetic mixture analyses. From the placebo analysis, it was confirmed that the change in the titrant value with respect to the water blank was caused only by the analyte. To identify the interference by common tablet excipients, a synthetic mixture with the composition of BUPH (200 mg), talc (80 mg), starch (160 mg), calcium gluconate (80 mg), lactose (80 mg), sodium alginate (40 mg) and magnesium stearate (40 mg) was prepared and subjected to analysis by the proposed methods after solution preparation using the procedure described for tablets. The percent recoveries of BUPH were 98.46±1.64 (n = 5) and 99.41±1.21 (n = 5) by methods A and B, respectively, suggesting no significant interference by the excipients in the assay of BUPH under the described optimum conditions. The compounds which contain basic nitrogen atom such as amines, ammonium compounds and alkaloids are expected to interfere in the assay.
Application to tablets
The proposed methods were successfully applied to the determination of BUPH in two representative tablets bupron-SR-150 and ession-ER-150. The results obtained are shown in Table 2 and were compared with those obtained by the comparison method [23] by means of Student's t-and F-tests at 95% confidence level. The Student's test has been used since only two methods were compared at the time, i.e., method A with the comparison method and method B with the comparison method, separately. The comparison method involved the visual titration of the drug with acetous perchloric acid in non aqueous medium using crystal violet as indicator. In all the cases, the average results obtained by the proposed methods and comparison method were statistically identical, as the difference between the average values was insignificant at 95% confidence level with respect to accuracy and precision. Accuracy of the proposed methods was further confirmed using the standard addition procedure. Pre-analyzed tablet powder (bupron-SR-150 and ession-ER-150) was spiked with then there are no significant differences between the two mean values or the variances of the proposed methods and the comparison method pure BUPH at three different concentration levels (50, 100 and 150% of the quantity present in the tablet powder) and the total was measured by the proposed methods. The determination with each amount was repeated three times and the results of this study presented in Table 3 indicated that the various excipients present in the formulations did not interfere in the assay.
CONCLUSIONS
Two useful methods for the determination of BUPH were developed, optimized and validated based on ion-pair extraction titration. The ion-pair extraction titrimetry would be convenient for use in the laboratory, because, there is no need for sophisticated instrumentation. The method B is more preferable then method A as the detection of the end point is clearer in method B. The proposed methods are simple, accurate, rapid and cheap in the cost of analysis compared with previously reported methods. The procedures do not involve any critical reaction conditions or tedious sample preparation. The wide applicability of the proposed procedures for routine quality control is well established by the assay of BUPH in pure form and in pharmaceutical preparations. 
